IN8bio, Inc. (INAB)
1.09
-0.05
(-4.39%)
USD |
NASDAQ |
Sep 09, 13:38
IN8bio Total Assets (Quarterly) : 21.74M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.74M |
| March 31, 2026 | 26.26M |
| December 31, 2025 | 32.28M |
| September 30, 2025 | 16.77M |
| June 30, 2025 | 19.37M |
| March 31, 2025 | 19.87M |
| December 31, 2024 | 21.99M |
| September 30, 2024 | 15.97M |
| June 30, 2024 | 22.50M |
| March 31, 2024 | 25.55M |
| December 31, 2023 | 33.71M |
| Date | Value |
|---|---|
| September 30, 2023 | 26.21M |
| June 30, 2023 | 29.72M |
| March 31, 2023 | 24.68M |
| December 31, 2022 | 33.04M |
| September 30, 2022 | 38.38M |
| June 30, 2022 | 30.99M |
| March 31, 2022 | 36.54M |
| December 31, 2021 | 42.22M |
| September 30, 2021 | 47.13M |
| June 30, 2021 | |
| March 31, 2021 | 20.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.382M |
| Shareholders Equity (Quarterly) | 18.36M |
| Debt to Equity Ratio | 0.1186 |
| Current Ratio | 8.206 |
| Net Debt Paydown Yield | 3.02% |